Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

87 publications

Funding

6 grantsView NIH portfolio on RePORTER ↗

Active

3 grants
  • MPI
    A Phase 2 Trial of Darolutamide plus Leuprolide Acetate in Advanced Androgen Receptor Positive Salivary Gland Cancer
    NIH · 2026–2030 · via NIH RePORTER
    R01FD008542-01A1
  • PI
    Phase II trial of avutometinib plus defactinib in RAF dimer-driven thyroid cancers
    NIH · 2024–2028 · via NIH RePORTER
    R01FD008181-03
  • MPI
    Improving efficacy of radioiodine treatment of thyroid cancer
    NCI · 2021–2026 · via NIH RePORTER
    R01CA249663-05
Completed grants (3)
  • MPI
    Identifying and targeting neoantigens in aggressive salivary carcinomas
    NIDCR · 2018–2024 · via NIH RePORTER
    R01DE027738-05
  • PI
    Targeting MEK to Restore Radioiodine Efficacy for RAI-Refractory Thyroid Cancer
    NCI · 2015–2020 · via NIH RePORTER
    R01CA184724-03
  • PI
    Targeting the Oncogenic Transcription Factor c-myb in Adenoid Cystic Carcinomas
    NCI · 2012–2015 · via NIH RePORTER
    R01CA166978-02